Market Research Report

Global Molecular Diagnostics (MDx) Point of Care Market Analysis, 2020

Global Molecular Diagnostics (MDx) Point-of-Care Market Analysis, 2020, By Application (Infectious Disease, Oncology, Hematology, Prenatal Testing, Endocrinology, Others), By Prod...uct (Assays, Software, Services), By Technology (Isothermal Nucleic Acid Amplification Technology (INAAT), Polymerase Chain Reaction (Digital PCR,, Real Time PCR), Others, By Test-Location (OTC (Over-the-counter), POC (Point-of-care), By End-User (Decentralized Labs, Hospitals, Homecare, Assisted Living Healthcare Facilities, Others), By Region (North America, South America, Europe, Asia-Pacific, Middle East & Africa), By Country (US, Canada, Mexico, Brazil, Argentina, Germany, France, UK , Spain, Italy, China, Japan, South Korea, India, Australia, Saudi Arabia, UAE) By Company Read more

  • Healthcare
  • May 2020
  • Pages 193
  • Report Format: PDF, Excel, PPT

US Reciprocal Tax Impact on Markets: Stay Informed with Expert Insights and Real-Time Updates

Global Molecular Diagnostics (MDx) Point of Care Market Analysis, 2020 research report depicts a deep-dive market analysis of statistics of Global Molecular Diagnostics (MDx) Point of Care market which consists of regional and country-wise market size, market forecast, CAGR market segmentation, market shares of diverse regions and countries, market share of various end users, applications, product type, technologies, competitive benchmarking, etc.

The prevalence of diseases such as infectious diseases in developing countries as well as less developed countries is surging due to improving healthcare infrastructure and the preference of patients for efficient home care. Moreover, suitable government norms and extensive support are also helping in the market growth of MDx Point of Care market. According to MarkNtel Advisors’ research report titled “Global Molecular Diagnostics (MDx) Point of Care Market Analysis, 2020”, the Global Molecular Diagnostics (MDx) Point of Care market is anticipated to grow at a CAGR of around 13% during 2020-25. However, a lack of arrangement with test results obtained from laboratories, strict & tedious approval policies are expected to restrain the market growth. 

Assays are expected to grab the largest market share in the Global Molecular Diagnostics Point of Care market during 2020-25. The assays are uniquely intended for points of care such as hospital critical care units, Specialty clinics, and other healthcare services delivery centers.

North America dominated the Global Mdx Point of Care market in 2019. The same trend is set to prevail during the forecast period. However, the year-on-year growth of Asia-Pacific is set to outperform other geographies during the same period. The region is forecast to grow at a CAGR of around 15.89% during 2020-25, as stated in the MarkNtel Advisors’ research report “Global Molecular Diagnostics (MDx) Point of Care Market Analysis, 2020”.

According to MarkNtel Advisors, Abbott Laboratories, Mesa Biotech, Hologic, Qiagen, F. Hoffmann, Siemens Healthineers, DxNA, Johnson & Johnson, Roche Diagnostics, Danaher Corporation, EKF Diagnostics, Becton Dickinson, Trinty Biotech, and Quidel are few of the leading players in the Global Molecular Diagnostics (MDx) Point of Care Market.



Key Questions Answered in the Market Research Report 

  1. What are the key overall market statistics or market estimates (Market Overview, Market Size- By Value, Forecast, Market Segmentation, Market Shares) of Global Molecular Diagnostics (MDx) Point of Care Market?
  2. What are the region wise industry size, growth drivers and challenges key market trends?
  3. What are the key innovations, technology upgrades, opportunities, regulations in the Global Molecular Diagnostics (MDx) Point of Care Market?  
  4. Who are the key competitors or market players and how they perform in Global Molecular Diagnostics (MDx) Point of Care Market on the basis of competitive benchmarking matrix?
  5. What are the key results derived from the market surveys conducted during the course of Global Molecular Diagnostics (MDx) Point of Care Market study?   

Market Outlook, Segmentation and Statistics

  • Market Size & Analysis
    • By Revenues
  • Market Share & Analysis
    • By Application
      • Infectious Diseases
      • Oncology
      • Hematology
      • Prenatal Testing
      • Endocrinology
      • Others
    • By Technology
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • Polymerase Chain Reaction (PCR)
      • Digital PCR
      • Real Time PCR
      • Others
    • By Product
      • Assays
      • Software
      • Services
    • By Test-Location
      • OTC (Over-the-counter)
      • POC (Point-of-care)
    • By End-User
      • Decentralized Labs
      • Hospitals
      • Homecare
      • Assisted Living Healthcare Facilities
      • Others 
    • By Company
      • Revenue Shares
      • Strategic Factorial Indexing
      • Competitor Placement in MarkNtel Quadrant
    • By Region
      • North America Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
        • The United States Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
        • Canada Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
        • Mexico Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
      • South America Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
        • Brazil Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
        • Argentina Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
        • Rest of South America Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
      • Europe Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
        • The UK Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
        • Germany Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
        • France Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
        • Italy Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
        • Spain Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
        • Rest of Europe Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
      • Middle East & Africa Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
        • UAE Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
        • Saudi Arabia Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
        • Rest of Middle East & Africa Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
      • Asia-Pacific Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
        • China Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
        • Japan Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
        • India Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
        • Australia and New Zealand Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
        • South Korea Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
        • Rest of Asia Pacific Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
  • Global Molecular Diagnostics (MDx) Point of Care Market Policies, Regulations, Product Standard
  • Global Molecular Diagnostics (MDx) Point of Care Market Intellectual Property Rights Analysis
  • Global Molecular Diagnostics (MDx) Point of Care Market Hotspots & Opportunities
  • Competition Outlook
    • Competitor Wise Growth Strategies
    • Company Profiles

Frequently Asked Questions 

Q. What is the historical year, base year and forecast year considered in the research report on Global Molecular Diagnostics (MDx) Point of Care Market?
A. The historical data has been provided since 2015, while the base year is 2019 and the data is forecast up-to 2025.

Q. What would be the growth rate or CAGR of the Global Molecular Diagnostics (MDx) Point of Care Market during 2020-25?
A. The growth rate of the Global Molecular Diagnostics (MDx) Point of Care Market during 2020-25 is forecast to be around 13%

Q. Who are the key competitors or players operating in the Global Molecular Diagnostics (MDx) Point of Care Market? 
A. Mesa Biotech, Hologic, Qiagen, F. Hoffmann, Siemens Healthineers, DxNA, Johnson & Johnson, Roche Diagnostics, Danaher Corporation, EKF Diagnostics, Becton Dickinson, Trinty Biotech, Quidel, etc., are few of the leading players in the Global Molecular Diagnostics (MDx) Point of Care Market.

Q. Which end-user segment would emerge as an opportunity area for players in Global Molecular Diagnostics (MDx) Point of Care Market?
A. The hospital segment is expected to attain the highest CAGR during the forecast period and maintain its significant market share.

Q. Which region would emerge as an opportunity area for players in Global Molecular Diagnostics (MDx) Point of Care Market?
A. North America region grabbed a significant market share continues to grow at the highest CAGR, presenting immense opportunities for manufacturers and suppliers of the Global Molecular Diagnostics (MDx) Point of Care Market.

Don't Need a Global Report? Focus on reports for specific countries and regions

Frequently Asked Questions

   A. The historical data has been provided since 2015, while the base year is 2019 and the data is forecast up-to 2025.

  1. Introduction
    1. Product Definition
    2. Research Process
    3. Glossary
    4. Market Segmentation
  2. Executive Summary
  3. Start-up Ecosystem
  4. Expert Verbatim- Interview Excerpts of 10 industry experts
  5. Global Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Application
        1. Infectious Diseases
        2. Oncology
        3. Hematology
        4. Prenatal Testing
        5. Endocrinology
        6. Others
      2. By Technology
        1. Isothermal Nucleic Acid Amplification Technology (INAAT)
        2. Polymerase Chain Reaction (PCR)
          1. Digital PCR
          2. Real Time PCR
        3. Others
      3. By Product
        1. Assays
        2. Software
        3. Services
      4. By Test-Location
        1. OTC (Over-the-counter)
        2. POC (Point-of-care)
      5. By End-User
        1. Decentralized Labs
        2. Hospitals
        3. Homecare
        4. Assisted Living Healthcare Facilities
        5. Others
      6. By Region
        1. North America
        2. South America
        3. Europe
        4. Asia-Pacific
        5. Middle East & Africa
      7. By Company
        1. Revenue Shares
        2. Strategic Factorial Indexing
        3. Competitor Placement in MarkNtel Quadrant
  6. North America Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Application
      2. By Product
      3. By Test-Location
      4. By End-User
      5. By Technology
      6. By Country
        1. US
        2. Canada
        3. Mexico
    3. US Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
    4. Canada Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
    5. Mexico Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
  7. South America Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Application
      2. By Product
      3. By Test-Location
      4. By End-User
      5. By Country
        1. Brazil
        2. Argentina
        3. Others
    3. Brazil Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
    4. Argentina Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
  8. Europe Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Application
      2. By Product
      3. By Test-Location
      4. By End-User
      5. By Technology
      6. By Country
        1. The UK
        2. Germany
        3. France
        4. Italy
        5. Spain
        6. Others
    3. UK Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
    4. Germany Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
    5. France Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
    6. Italy Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
    7. Spain Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
  9. Asia-Pacific Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Application
      2. By Product
      3. By Test-Location
      4. By End-User
      5. By Technology
      6. By Country
        1. China
        2. India
        3. Japan
        4. Australia
        5. South Korea
        6. Others
    3. China Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
    4. India Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
    5. Japan Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
    6. Australia Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
    7. South Korea Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
  10. Middle East and Africa Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Application
      2. By Product
      3. By Test-Location
      4. By End-User
      5. By Technology
      6. By Country
        1. UAE
        2. Saudi Arabia
        3. Others
    3. UAE Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
    4. Saudi Arabia Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
  11. Global Molecular Diagnostics (MDx) Point-of-Care Dynamics
    1. Drivers
    2. Challenges
    3. Impact Analysis
  12. Global Molecular Diagnostics (MDx) Point-of-Care Region Wise Regulations, Product Standards
  13. Global Molecular Diagnostics (MDx) Point-of-Care Hotspots & Opportunities
  14. Competition Outlook
    1. Competitor Wise Growth Strategies
      1. Product Portfolio
      2. Brand Specialization
      3. Target Markets
      4. Research & Development
      5. Strategic Alliances & Initiatives
      6. Merges & Acquisitions
    2. Company Profiles
      1. Abbott Laboratories
      2. Mesa Biotech
      3. Hologic, Inc.
      4. QIAGEN N.V
      5.  F. Hoffmann-La Roche Ltd
      6. DxNA LLC Group Ltd
      7. Luminex Corporation
      8. Siemens Healthineers
      9. Johnson & Johnson
      10. Roche Diagnostics
      11. Danaher Corporation
      12. EKF Diagnostics
      13. Becton Dickison
      14. Trinty Biotech
      15. Quidel Corporation
  15. Disclaimer


MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

Data Trangulation

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making